Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Breast cancer Stories

2014-03-25 08:27:28

- Livenation.com and Ticketmaster.com Give Fans Opportunity to Help Fight Cancer through April 13, 2014 - LOS ANGELES, March 25, 2014 /PRNewswire/ -- Live Nation Entertainment (NYSE: LYV) and the American Cancer Society announced today a collaboration to raise awareness of cancer issues and critically needed funds to help finish the fight. http://photos.prnewswire.com/prnvar/20140325/LA85683LOGO Fans of concerts, sports, theater and family events can make a donation to help fight...

2014-03-24 20:22:55

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/czqbv2/investigation) has announced the addition of the "Investigation Report on China Trastuzumab Market, 2009-2018" [http://www.researchandmarkets.com/research/czqbv2/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Trastuzumab is a monoclonal antibody that interferes with the HER2/neu receptor. Its main...

2014-03-24 08:28:34

SAN DIEGO, March 24, 2014 /PRNewswire/ -- Seragon Pharmaceuticals Inc., a clinical-stage biotechnology company focused on the development of drugs for hormone-driven cancers, today announced the appointment of N. Anthony Coles (Tony), M.D. to the company's Board of Directors. Dr. Coles brings nearly 30 years of experience in the healthcare, biotechnology and pharmaceutical industries. Most recently, Dr. Coles served as President, Chief Executive Officer and Chairman of the Board of...

2014-03-24 08:27:56

Foremost research organization uses Web of Science to evaluate and enhance funding decisions PHILADELPHIA, March 24, 2014 /PRNewswire/ -- The Intellectual Property & Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced a collaboration with Susan G. Komen®, the world's largest breast cancer organization. As part of this relationship, Susan G. Komen will have special access to Thomson Reuters...

2014-03-22 23:04:05

Pretty In Pink Foundation achieves business milestone while providing hope and healing to underinsured and uninsured North Carolinians diagnosed with breast cancer Raleigh, NC (PRWEB) March 22, 2014 Headquartered in Raleigh, North Carolina under the leadership of its Founder Dr. Lisa Tolnitch, Pretty In Pink Foundation (http://www.prettyinpinkfoundation.org) proudly celebrates ten years of serving North Carolinian women and men diagnosed with breast cancer who are unable to pay for...

Mammograms Needed More Often For One-Third Of Women
2014-03-22 07:07:50

April Flowers for redOrbit.com - Your Universe Online While three-year intervals between mammograms are appropriate for most women, a new study from the UK NHS Breast Screening Program has found that one-third of women are at a higher risk of developing cancer. These women, according to the report delivered this week at the 9th European Breast Cancer Conference (EBCC-9), might benefit from more frequent mammograms. Professor Gareth Evans, from the University of Manchester, reported that...

2014-03-21 23:21:32

Lingerie experts Leia have revealed they are to team up with Breast Cancer Care (BCC), the breast cancer support charity, to promote the importance of breast health and benefits of professional bra fitting. Desborough, Northamptonshire (PRWEB) March 21, 2014 On Saturday 22nd March, from 9am to 9pm, visitors will be able to take advantage of professional bra fitting by the underwear specialist, whilst learning about breast health. As the most common cancer in the UK, Leia wants to advise...

2014-03-21 08:24:23

ROCKVILLE, Md., March 21, 2014 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, today reported financial results for the three and 12 months ended December 31, 2013. http://photos.prnewswire.com/prnvar/20010620/ENMDLOGO The Company reported a net loss of ($1.3 million), or ($0.05) per share for the three months ended December 31, 2013. This compares with net loss of ($0.4...

2014-03-20 23:22:02

Entinostat is being investigated in patients with advanced hormone receptor-positive breast cancer by the ECOG-ACRIN Cancer Research Group in its latest trial, E2112. Philadelphia, PA, and Waltham, MA (PRWEB) March 20, 2014 The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and Syndax Pharmaceuticals, Inc., announced today that patient recruitment has begun for E2112, a randomized phase III clinical trial of Syndax’s entinostat in treatment of patients with advanced breast cancer. The...

2014-03-20 23:01:42

Florida Hospital Tampa will feature clinical experts in the field of cancer on Tuesday, March 25th to educate the community on the latest information in cancer prevention, treatment, support and therapy. Tampa, Fl (PRWEB) March 20, 2014 Florida Hospital Tampa is hosting “A Cancer Symposium” with a focus on the three big c’s- breast, GI, and lung cancers to educate the community on prevention, treatment, support and therapy. This event is free to the public and will take place at...


Latest Breast cancer Reference Libraries

Clinical Breast Cancer
2012-06-04 20:06:33

Clinical Breast Cancer is a peer-reviewed medical journal established in 2000 and published bimonthly by Elsevier. As of May 2012, the editor-in-chief is George W. Sledge, Jr. The journal publishes original articles describing various aspects of clinical and translational research of breast cancer. It is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer....

Breast Cancer Research and Treatment
2012-05-07 07:48:55

Breast Cancer Research and Treatment is a peer-reviewed scientific journal published by Springer Verlag. It focuses on the treatment of and investigations in breast cancer. The journal is targeted towards a wide audience of clinical researchers, epidemiologists, immunologists, and cell biologists whom are interested in breast cancer. Articles in this journal include: original research, invited reviews, discussions on controversial issues, book reviews, meeting reports, letters to the editors,...

More Articles (2 articles) »